CELU
Celularity Inc.NASDAQHealthcare$1.40+5.26%ClosedMarket Cap: $33.7M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.84
P/S
0.83
EV/EBITDA
-1.58
DCF Value
$-168.73
FCF Yield
-19.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.3%
Operating Margin
-119.6%
Net Margin
-198.7%
ROE
763.3%
ROA
-70.6%
ROIC
-88.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $5.3M | 61.8% | $-12.9M | $-23.1M | $-0.88 | — |
| Q2 2025 | $5.7M | 8.6% | $-15.9M | $-24.5M | $-1.02 | — |
| Q1 2025 | $11.4M | 68.9% | $-10.5M | $-19.8M | $-0.84 | — |
| Q4 2024 | $18.1M | 59.5% | $-9.3M | $-13.3M | $-0.59 | — |
| FY 2024 | $54.2M | 72.4% | $-38.4M | $-57.9M | $-2.64 | — |
| Q3 2024 | $9.3M | 58.2% | $-11.5M | $-16.1M | $-0.73 | — |
| Q2 2024 | $12.1M | 82.5% | $-10.2M | $-6.5M | $-0.30 | — |
| Q1 2024 | $14.7M | 88.8% | $-7.4M | $-22.0M | $-1.03 | — |
| Q4 2023 | $12.1M | 20.7% | $13.3M | $9.5M | $0.49 | — |
| FY 2023 | $22.8M | 29.7% | $-192.3M | $-196.3M | $-11.02 | — |
| Q3 2023 | $3.8M | 4.9% | $-99.3M | $-93.9M | $-4.99 | — |
| Q2 2023 | $2.9M | 72.7% | $-42.5M | $-47.9M | $-2.72 | — |